摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

伪石蒜碱 | 29429-03-6

中文名称
伪石蒜碱
中文别名
——
英文名称
pseudolycorine
英文别名
Pseudolycorin;(1S,14S,15S,16S)-5-methoxy-9-azatetracyclo[7.6.1.02,7.012,16]hexadeca-2,4,6,12-tetraene-4,14,15-triol
伪石蒜碱化学式
CAS
29429-03-6
化学式
C16H19NO4
mdl
——
分子量
289.331
InChiKey
CKAHWDNDUGDSLE-ARLBYUKCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    73.2
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    伪石蒜碱 在 selenium(IV) oxide 作用下, 以 乙醇 为溶剂, 反应 4.0h, 以5 mg的产率得到zefbetaine
    参考文献:
    名称:
    Ungeremine and Its Hemisynthesized Analogues as Bactericides against Flavobacterium columnare
    摘要:
    The Gram-negative bacterium Flavobacterium columnare is the cause of columnaris disease, which can occur in channel catfish (Ictalurus punctatus). In a previous study, the betaine-type alkaloid ungeremine, 1, obtained from Pancratium maritimum L. was found to have strong antibacterial activity against F. columnare. In this study, analogues of 1 were evaluated using a rapid bioassay for activity against F. columnare to determine if the analogues might provide greater antibacterial activity and to determine structure-activity relationships of the test compounds. Several ungeremine analogues were prepared by hydrochlorination of the alkaloid and by selenium dioxide oxidation of both lycorine, 7, and pseudolycorine, 8, which yielded the isomer of ungeremine, 3, and zefbetaine, 4, respectively. The treatment of lycorine with phosphorus oxychloride allowed the synthesis of an anhydrolycorine lactam, 5, showing, with respect to 1, the deoxygenation and oxygenation of C-2 and C-7 of the C and B rings, respectively. The results of the structure-activity relationship studies showed that the aromatization of the C ring and the oxidation to an azomethine group of C-7 of the B ring are structural features important for antibacterial activity. In addition, the position of the oxygenation of the C ring as well as the presence of the 1,3-dioxole ring joined to the A ring of the pyrrolo[de]phenanthridine skeleton also plays a significant role in imparting antibacterial activity. On the basis of 24-h 50% inhibition concentration (IC50) results, ungeremine hydrochloride, 2, was similar in toxicity to 1, whereas 5 had the lowest activity. Analogue 2 is soluble in water, which may provide the benefit for use as an effective feed additive or therapeutant compared to ungeremine.
    DOI:
    10.1021/jf304586j
点击查看最新优质反应信息

文献信息

  • Natural compounds and fibrosis
    申请人:MEDIZINISCHE HOCHSCHULE HANNOVER (MHH)
    公开号:US11185539B2
    公开(公告)日:2021-11-30
    The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.
    本发明涉及一种用于预防或治疗纤维化方法的 miR-671-5p 抑制剂。此外,本发明还包括一种包含所述 miR-671-5p 抑制剂的试剂盒。本发明还涉及一种用于鉴定预防或治疗纤维化的化合物的体外方法。
  • NATURAL COMPOUNDS AND FIBROSIS
    申请人:MEDIZINISCHE HOCHSCHULE HANNOVER (MHH)
    公开号:US20190350923A1
    公开(公告)日:2019-11-21
    The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.
  • [EN] NATURAL COMPOUNDS AND FIBROSIS<br/>[FR] COMPOSÉS NATURELS ET FIBROSE
    申请人:MEDIZINISCHE HOCHSCHULE HANNOVER MHH
    公开号:WO2018141678A1
    公开(公告)日:2018-08-09
    The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.
查看更多